METHYLPHENIDATE HYDROCHLORIDE
METHYLPHENIDATE HYDROCHLORIDE
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 206049 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2018-05-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHYLPHENIDATE HYDROCHLORIDE is listed in Drugs@FDA under application 206049 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHYLPHENIDATE HYDROCHLORIDE Form and strength FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML Sponsor ACTAVIS LABS FL INC Submission history Latest submission status date: 2018-05-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.